DSAM Partners’s Tandem Diabetes Care TNDM Stock Holding History

DSAM Partners’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-33,910	Closed	-$2.15M	–	128
2019 Q1	$2.15M	Buy	+33,910	New	+$1.78M	0.31%	50

Other funds holding TNDM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

DSAM Partners's TNDM Position: Q2 2019 in Review

DSAM Partners sold out of Tandem Diabetes Care (TNDM) in Q2 2019, closing a stake of 33,910 shares — an estimated $2.15M sold.

DSAM Partners first reported a position in TNDM in Q1 2019 and held it in 1 quarter. The position peaked at $2.15M in Q1 2019. 261 funds tracked by Wall St. Rank hold TNDM as of Q2 2019.

DSAM Partners reported no remaining Tandem Diabetes Care position as of Q2 2019 after selling out during the quarter.
DSAM Partners sold 33,910 Tandem Diabetes Care shares in Q2 2019, an estimated $2.15M.
DSAM Partners first reported a position in Tandem Diabetes Care in Q1 2019 and held it in 1 quarter.
DSAM Partners's Tandem Diabetes Care position peaked at $2.15M in Q1 2019.
261 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2019.

Based on DSAM Partners's 13F filing for Q2 2019, filed 14 Aug 2019.